Details of the Drug Inactive Ingredient (DIG)

General Information of DIG (ID: E0U6KS)
DIG Name
Cysteine hydrochloride
Synonyms    Click to Show/Hide the Synonyms of This DIG
DL-Cysteine hydrochloride; 10318-18-0; 2-amino-3-mercaptopropanoic acid hydrochloride; CYSTEINE HYDROCHLORIDE; DL-CYSTEINE HCL; H-DL-Cys-OH.HCl; H-D-Cys-OH HCl HO; MFCD00064552; Cystein chloride; NSC8746; DL-2-Amino-3-mercaptopropionic acid hydrochloride; H-D-Cys-OH.HCl.H2O; Cysteine chlorhydrate; (+-)-Cysteine hydrochloride; DL-Cysteine hydrochloride anhydrous; DL-Cysteine hydrochloride, 95%, anhydrous; CYSTEINE, HYDROCHLORIDE, DL-; EINECS 233-698-2; 3-Mercaptoalanine hydrochloride; L-Cysteine, hydrochloride (1:1); MFCD00012632; EK 2367; Cysteine chlorohydrate; H-DL-Cys-OH?Cl; L-Cystein-hydrochloride; ACMC-20al3w; DL-CysteineHydrochloride; H-DL-Cys.HCl.H2O; CYSTEINE, (L); 2-amino-3-sulfanylpropanoic acid hydrochloride; ACMC-20a6d7; (R)-Cysteine-hydrochloride; (RS)-cysteine hydrochloride; SCHEMBL18160; (2S)-2-amino-3-sulfanylpropanoic acid;hydrochloride; ARONIS005073; WLN: SH1YZVQ &GH -L; DTXSID00920537; Pharmakon1600-01300014; Cysteine--hydrogen chloride (1/1); NSC755898; AKOS003726073; MCULE-7790846545; NSC-755898; AK-49861; DS-15293; SY033289; AB0068970; DB-007444; DB-048214; DB-052197; AM20070682; FT-0624466; FT-0627749; FT-0639023; FT-0650774; C-9675; M-5521; 2-azanyl-3-sulfanyl-propanoic acid hydrochloride; 318C180; A814830; DL-Cysteine hydrochloride, >=95% (TLC), anhydrous
DIG Function
Antioxidant
PubChem CID
25150
Formula
C3H8ClNO2S
Canonical SMILES
C(C(C(=O)O)N)S.Cl
InChI
1S/C3H7NO2S.ClH/c4-2(1-7)3(5)6;/h2,7H,1,4H2,(H,5,6);1H
InChIKey
IFQSXNOEEPCSLW-UHFFFAOYSA-N
   Click to Show/Hide the Molecular Data (Structure/Property) of This DIG
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=25150"></iframe>
3D MOL is not available 2D MOL
Physicochemical Properties Molecular Weight 157.62 Topological Polar Surface Area 64.3
XlogP N.A. Complexity 75.3
Heavy Atom Count 8 Rotatable Bond Count 2
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 4
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG
       ICD Disease Classification 06 Mental/behavioural/neurodevelopmental disorder Click to Show/Hide
Bupropion
 API Info
Nicotine dependence [ICD-11: 6C4A]
 [1]
Naltrexone
 API Info
Alcohol dependence [ICD-11: 6C40]
 [2]
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG
      Transferase (TFase)
            DBT Name: ABHD5-Perilipin complex (ABHD5-PLIN1) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity IC50 = 7335 nM (estimated based on the structural similarity with CHEMBL1426508 ) [3]
                    Structural Similarity Tanimoto coefficient = 0.826086957
                    Tested Species Homo sapiens (Human)
                    UniProt ID ABHD5_HUMAN ; PLIN1_HUMAN
References
1 FDA label for approved bupropion from the official website of the U.S. Food and Drug Administration.
2 FDA label for approved naltrexone from the official website of the U.S. Food and Drug Administration.
3 PubChem BioAssay data set.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.